A major breakthrough in cancer investigation is arising with the use of nanobodies to restore dysfunctional p53. This essential malignant inhibitor protein is frequently disabled in several types of tumors, leading https://bookmark-template.com/story30165187/nanobodies-reactivate-the-p53-protein-the-new-hope-for-tumor-management